Covered recipient · General Payments record
ANDREW JOSEPH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$326.31
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $326.31 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $148.41 | 3 |
| ABBVIE INC. | $49.57 | 3 |
| Mylan Specialty L.P. | $28.06 | 1 |
| Astellas Pharma US Inc | $24.61 | 1 |
| Nevro Corp. | $22.35 | 1 |
| Merck Sharp & Dohme Corporation | $19.55 | 1 |
| Amgen Inc. | $16.97 | 1 |
| Lilly USA, LLC | $16.79 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $326.31 | 12 |
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.37 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104011790 | CMS |
| ABBVIE INC. | $18.04 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104011792 | CMS |
| ABBVIE INC. | $16.16 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104011794 | CMS |
| Amgen Inc. | $16.97 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117290937 | CMS |
| Astellas Pharma US Inc | $24.61 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139449142 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.01 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104328044 | CMS |
| AstraZeneca Pharmaceuticals LP | $9.54 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105368106 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.86 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104496784 | CMS |
| Lilly USA, LLC | $16.79 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136040167 | CMS |
| Merck Sharp & Dohme LLC | $19.55 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141966153 | CMS |
| Mylan Specialty L.P. | $28.06 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147360266 | CMS |
| Nevro Corp. | $22.35 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130769724 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.